However, it remains unclear whether the medication itself, or some other factor, is responsible for that increased risk, researchers reported in the Journal of Allergy and Clinical Immunology.
"This association does not prove that the medicines caused asthma in these children," said Aziz Sheikh, co-director of the Asthma UK Centre for Applied Research at the University of Edinburgh and co-author of the study.
"Further research is needed to better understand this link."
Heartburn -- discomfort caused by acid passing from the stomach up into the oesophagus -- occurs frequently during pregnancy due to hormonal changes and pressure on the stomach from the expanding womb.
Previous research had inconclusively pointed to an increased risk of allergies in offspring due to an impact on the immune system.
To dig deeper, scientists from Edinburgh and Finland reviewed eight previous studies involving more than 1.3 million children, drawing on healthcare registries and prescription databases.
They found that children born of mothers taking antacids were at least a third more likely to have visited a doctor for asthma symptoms.
Asthma is a chronic lung disease that inflames and narrows the airways. It frequently starts in childhood.
More that 330 million people worldwide suffer from asthma, with an especially high incidence in low- and middle-income countries, according to The Global Asthma Report 2014.
Experts commenting on the study did not challenge the link between the heartburn drugs and asthma in kids, but cautioned against jumping to conclusions.
"It may be that the heartburn in itself may be the most important association rather than the drugs used to treat it," said Jean Golding, an emeritus professor of paediatric epidemiology at the University of Bristol.
Obesity in the expecting mother could also play a key role, said Seif Shaheen, a respiratory epidemiologist at Queen Mary University of London, noting that few of the studies took this factor into account.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
